Zhu LY, Hou JC, Yang L, Liu ZR, Tong W, Bai Y, Zhang YM. Application value of mixed reality in hepatectomy for hepatocellular carcinoma. World J Gastrointest Surg 2022; 14(1): 36-45 [PMID: 35126861 DOI: 10.4240/wjgs.v14.i1.36]
Corresponding Author of This Article
Ya-Min Zhang, MD, Chief Doctor, Department of Hepatobiliary Surgery, Tianjin First Central Hospital, No. 24 Fukang road, Nankai District, Tianjin 300192, China. 13802122219@163.com
Research Domain of This Article
Surgery
Article-Type of This Article
Retrospective Cohort Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Surg. Jan 27, 2022; 14(1): 36-45 Published online Jan 27, 2022. doi: 10.4240/wjgs.v14.i1.36
Application value of mixed reality in hepatectomy for hepatocellular carcinoma
Liu-Yang Zhu, Jian-Cun Hou, Long Yang, Zi-Rong Liu, Wen Tong, Yi Bai, Ya-Min Zhang
Liu-Yang Zhu, Wen Tong, First Central Clinical College, Tianjin Medical University, Tianjin 300070, China
Jian-Cun Hou, Long Yang, Zi-Rong Liu, Yi Bai, Ya-Min Zhang, Department of Hepatobiliary Surgery, Tianjin First Central Hospital, Tianjin 300192, China
Author contributions: Zhu LY, Hou JC and Zhang YM designed the research; Zhu LY, Liu ZR, Tong W and Bai Y collected and analyzed the data; Zhu LY and Yang L wrote the paper; Hou JC and Zhang YM revised the paper.
Supported byScience and Technology Planning Projects of Tianjin, No. 19ZXDBSY00010; and Science and Technology Project of Tianjin Health Commission, No. ZC20174.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of the Tianjin first Central Hospital.
Informed consent statement: Patients were not required to give informed consent for the study because the clinical data were obtained retrospectively after each patient agreed to treatment by written consent.
Conflict-of-interest statement: All the Authors have no conflict of interest related to the manuscript.
Data sharing statement: No additional data are available.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ya-Min Zhang, MD, Chief Doctor, Department of Hepatobiliary Surgery, Tianjin First Central Hospital, No. 24 Fukang road, Nankai District, Tianjin 300192, China. 13802122219@163.com
Received: October 4, 2021 Peer-review started: October 4, 2021 First decision: November 18, 2021 Revised: November 29, 2021 Accepted: December 25, 2021 Article in press: December 25, 2021 Published online: January 27, 2022 Processing time: 106 Days and 16.3 Hours
ARTICLE HIGHLIGHTS
Research background
As a new digital holographic imaging technology, mixed reality (MR) it has been preliminarily applied in hepatectomy for hepatocellular carcinoma (HCC). In this study, 95 patients with HCC who underwent hepatectomy were retrospectively analyzed to evaluate the application value of MR.
Research motivation
MR has been gradually applied to neurosurgery, orthopedics, and urology with an improvement in perioperative outcomes. MR may also have great potential in hepatectomy by preoperative planning and intraoperative navigation.
Research objectives
The aim of this study was to explore the application value of MR technology in hepatectomy for HCC.
Research methods
Total 95 patients with HCC were enrolled in the study, including 38 patients who underwent MR-assisted hepatectomy in Group A and 57 patients who underwent hepatectomy with traditional methods in Group B. Perioperative variables of the two groups of patients were collected and compared.
Research results
MR-assisted hepatectomy could significantly reduce the operation time, obstructive time of the portal vein, and the volume of bleeding. And the recovery of alanine aminotransferas and albumin in patients with MR-assisted hepatectomy was faster.
Research conclusions
MR significantly improved the perioperative outcomes of hepatectomy for HCC.
Research perspectives
MR may also have a certain application potential for laparoscopic and robotic hepatectomy, and it will be explored in future.
